Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1971 Nov;24(8):726–731. doi: 10.1136/jcp.24.8.726

The distribution of plasminogen activator in the male genital tract

R C Kester 1
PMCID: PMC477143  PMID: 5130539

Abstract

The distribution of fibrinolytic activity in the tissues of the male genital tract was studied by a histological technique. Preparations made from testis, epididymis, vas deferens, seminal vesicle, prostate, bulbo-urethral gland, and urethra showed that most activity was related to the blood vessels. However, inconsistent fibrinolytic activity related to epithelium was found in all parts of the genital tract. This epithelial activity was least in the testis, greater in the seminal vesicle and prostate gland, and was greatest in the bulbo-urethral gland and terminal urethra. No fibrinolytic activity could be demonstrated in relation to spermatozoa.

Full text

PDF
726

Images in this article

728Image
on p.728
728Image
on p.728
728Image
on p.728
729Image
on p.729
729Image
on p.729
730Image
on p.730
730Image
on p.730

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBRECHTSEN O. K. The fibrinolytic activity of human tissues. Br J Haematol. 1957 Jul;3(3):284–291. doi: 10.1111/j.1365-2141.1957.tb05798.x. [DOI] [PubMed] [Google Scholar]
  2. ASTRUP T., STERNDORFF I. An activator of plasminogen in normal urine. Proc Soc Exp Biol Med. 1952 Dec;81(3):675–678. doi: 10.3181/00379727-81-19983. [DOI] [PubMed] [Google Scholar]
  3. Charlton C. A. Pathogenesis of urolithiasis: relation of urinary fibrinolytic activity to nondialyzable urinary solids. Surg Forum. 1966;17:503–505. [PubMed] [Google Scholar]
  4. KARHAUSEN L., TAGNON H. Le syndrome de fibrinolyse prostatique; nature de l'activité protéolytique de la prostate. Acta Clin Belg. 1955 Nov-Dec;10(6):471–476. doi: 10.1080/17843286.1955.11717370. [DOI] [PubMed] [Google Scholar]
  5. Kester R. C. Plasminogen activator in the human prostate. J Clin Pathol. 1969 Jul;22(4):442–446. doi: 10.1136/jcp.22.4.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. LADEHOFF A. A. The content of plasminogen activator in the human urinary tract. Scand J Clin Lab Invest. 1960;12:136–139. [PubMed] [Google Scholar]
  7. Pandolfi M., Astrup T. A histochemical study of the fibrinolytic activity. Cornea, conjunctiva, and lacrimal gland. Arch Ophthalmol. 1967 Feb;77(2):258–264. doi: 10.1001/archopht.1967.00980020260022. [DOI] [PubMed] [Google Scholar]
  8. RASMUSSEN J., ALBRECHTSEN O. K. Characterization of the fibrinolytic components in the human prostate. Scand J Clin Lab Invest. 1960;12:261–268. doi: 10.3109/00365516009062435. [DOI] [PubMed] [Google Scholar]
  9. TODD A. S. LOCALIZATION OF FIBRINOLYTIC ACTIVITY IN TISSUES. Br Med Bull. 1964 Sep;20:210–212. doi: 10.1093/oxfordjournals.bmb.a070333. [DOI] [PubMed] [Google Scholar]
  10. TODD A. S. The histological localisation of fibrinolysin activator. J Pathol Bacteriol. 1959 Jul;78:281–283. doi: 10.1002/path.1700780131. [DOI] [PubMed] [Google Scholar]
  11. Tympanidis K., Astrup T. Fibrinolytic activity of rat, rabbit, and human sperm cells. Proc Soc Exp Biol Med. 1968 Oct;129(1):179–182. doi: 10.3181/00379727-129-33278. [DOI] [PubMed] [Google Scholar]
  12. VON KAULLA K. N., SHETTLES L. B. Relationship between human seminal fluid and the fibrinolytic system. Proc Soc Exp Biol Med. 1953 Aug-Sep;83(4):692–694. doi: 10.3181/00379727-83-20461. [DOI] [PubMed] [Google Scholar]
  13. YING S. H., DAY E., WHITMORE W. F., Jr, TAGNON H. J. Fibrinolytic activity in human prostatic fluid and semen. Fertil Steril. 1956 Jan-Feb;7(1):80–87. doi: 10.1016/s0015-0282(16)32230-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES